Chair Clemens Wendtner will lead Anne-Sophie Michallet, Talha Munir, Helen Parry, and Alessandra Tedeschi on a voyage through key issues in the management of patients with CLL.

This engaging session will explore:

Factors influencing individualized treatment selection in CLL
A closer look at the patient and disease factors that guide treatment decisions—and the clinical data that support those choices.

Managing infection risks in CLL
A specialist-led overview of one of the most critical aspects of care for patients living with CLL, including evolving tools and strategies for infection prophylaxis.

Critical questions in CLL
Discussion on expectations for efficacy, safety, and practicality across treatment modalities, along with the current and future role of minimal residual disease (MRD) in CLL management.

Gain clinically relevant insights and up-to-date guidance to enhance outcomes for your patients with CLL.